Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases

BACKGROUND: Data about safety and efficacy of the mRNA SARS-CoV-2 vaccine in adolescents with rheumatic diseases (RD) is scarce and whether these patients generate a sufficient immune response to the vaccine remains an outstanding question. OBJECTIVE: To evaluate safety and humoral and cellular immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Udaondo, Clara, Cámara, Carmen, Miguel Berenguel, Laura, Alcobendas Rueda, Rosa, Muñoz Gómez, Celia, Millán Longo, Claudia, Díaz – Delgado, Blanca, Falces-Romero, Iker, Díaz Almirón, Mariana, Ochando, Jordi, Méndez – Echevarría, Ana, Remesal Camba, Agustín, Calvo, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375068/
https://www.ncbi.nlm.nih.gov/pubmed/35964130
http://dx.doi.org/10.1186/s12969-022-00724-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375068/
https://www.ncbi.nlm.nih.gov/pubmed/35964130
http://dx.doi.org/10.1186/s12969-022-00724-4

Ejemplares similares